Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

NX-1207 produces significant clinical improvement in BPH

Feb. 2, 2004

Two novel series of prostanoid IP antagonists discovered at Bayer

Feb. 2, 2004

Takeda patent covers novel tachykinin antagonists with utility in urinary disorders

Jan. 30, 2004

Ro-1151240 in stress urinary incontinence

Jan. 29, 2004

Vanilloid agonists effective in detrusor hyperreflexia

Jan. 29, 2004

Finasteride superior to saw palmetto in chronic prostatitis/chronic pelvic pain syndrome

Jan. 28, 2004

Dose-dependent improvements found with solifenacin in urinary incontinence

Jan. 26, 2004

Pharmacological profile of 5-HT2C agonist YM-348

Jan. 21, 2004

AnorMED expands Fosrenol licensing agreement

Jan. 21, 2004

New tachykinin antagonists for urinary disorders and other uses

Jan. 14, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...